• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    BMP Medical Expands Sterling, Massachusetts Facility

    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy

    Environmental Sustainability Becoming Increasingly Important to Medtech Industry

    Duane DiFranco Joins Harvard MedTech’s Medical Advisory Board

    Lionel Bonte Named President of Mativ’s Healthcare and Wellness Business Unit
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Medbio LLC

    LEMO USA Inc.

    Providence Enterprise USA Inc.

    Arthur G. Russell Co. Inc., The

    JBC Technologies
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Medbio LLC

    LEMO USA Inc.

    Providence Enterprise USA Inc.

    Arthur G. Russell Co. Inc., The

    JBC Technologies
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    C-Suite Challenges in Medtech’s New Normal

    Many of the usual C-Suite management topics that are key to organizational success will remain the same this year.

    C-Suite Challenges in Medtech’s New Normal
    Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors02.03.21
    Every year, there’s a lot of discussion about healthcare’s constantly changing dynamics. In 2021, market opportunities like the growth in digital health, robotics, artificial intelligence, and telemedicine are sure to be among the top trends. We undoubtedly will be expanding on these topics throughout the year.

    The same matters took center stage in 2020, with certain market opportunities actually enhanced by the health crisis (telemedicine and digital health, most notably). These particular segments will experience significant growth this year as COVID-19 continues to force a physical divide between doctors and patients.

    Although a “new normal” has emerged in medtech—the virus will certainly loom large over the industry for quite some time—many of the usual C-Suite management topics that are key to organizational success will remain the same this year, though they’ll have to be regularly fine-tuned. Priorities are likely to include “organic” functional disciplines (i.e., sales and marketing, supply chain, regulatory, manufacturing, and employee engagement) as well as inorganic strategies for properly timing potential M&A deals.

    Let’s examine the organic topics in further detail.

    Sales
    Medical technology companies that sell directly to hospitals will continue to grapple with the immediate challenge of customer access. Put simply: It’s going to be difficult at best for sales teams to physically meet with customers as long as the virus is still a threat. Large firms are mostly embracing the restrictions barring sales representatives from hospitals for three main reasons. The first involves “leverage and bundling,” a process by which these entities leverage their market share and bundle their products to make it easy for hospitals to continue using their products. The second is directly related to finances.

    Since the pandemic began, many large companies have reduced the size of their sales force and saved significant money on travel since there have been no in-person customer visits or industry events.

    Finally, large organizations have quickly pivoted to create digital customer engagement experiences, thanks largely to their investment funding (this will also lower sales costs for the foreseeable future). Such a strategy makes it more difficult for small and medium-sized companies to compete and gain market share.

    Medtech manufacturers and suppliers that sell to OEMs have less arduous sales challenges, as their business-to-business outreach can be conducted remotely for the time being. However, gaining new business and establishing new relationships through phone calls and video conferencing can be quite tricky.

    Marketing
    Certainly, marketing teams will have to improve their “digital reach” this year as live events continue to fall victim to the virus in the near future. While some exposure in the short-term can be maintained by advertising, it’s going to be imperative that medtech companies hone their digital marketing skill sets through social media, personalized emails, and customer reviews, among other strategies. Clients—for the most part—are still working remotely so reaching them safely online will be key to driving successful marketing campaigns.

    Manufacturing
    Medtech companies’ priorities in 2021 will be to keep production teams healthy and manufacturing lines operating uninterrupted. Employee safety has become an even higher concern now for obvious reasons. When future planning most years, the manufacturing discussion has often been about location and/or automation strategy. But other than reshoring initiatives (a separate topic in itself), there likely will be little dialogue this year about global production transitions because COVID-19 is preventing businesses and workers from moving about freely. If possible, however, companies should expedite efforts to incorporate automation in the final or sub-assembly of finished products. Taking the human factor out of manufacturing has always made sense economically and functionally, as it yields quality products. With COVID-19 now in play, it is even more essential because it also helps to remove some production risks.

    Supply Chain
    Typically the lifeblood of any manufacturing operation, the supply chain is usually reviewed regularly for various reasons. Not only can supply chains help save money, they also can produce significant revenue for some organizations. Such diversity necessitates flexibility among suppliers, since objectives can change quickly depending on a company’s strategic goal. Supply chain professionals are consistently increasing the productivity of existing suppliers and finding new providers to facilitate less costly manufacturing that produces better quality medical products. This kind of supply chain management usually requires global travel but COVID-19 is preventing the kind of interpersonal relations needed for supplier improvement. While the virus will not completely make the influx of new suppliers impossible, it will create some interesting challenges (and time delays) regarding validation.

    Regulatory
    Incredible as it seems, the global pandemic has been a blessing of sorts for companies conducting business in Europe, as the European Union was forced to delay implementation of its MDR system until May this year. Many medtech companies had hoped for a delay once it became clear the 2020 deadline would wipe a number of products off the market. Anxiety over the MDR is sure to return as the deadline approaches (May 26) but hopefully regulatory teams have used the extra year to prepare for this highly burdensome set of rules. Regardless of a company’s readiness for MDR compliance, however, the new set of rules will require continued C-Suite oversight because they impact both new products and those already on the market.

    Employee Engagement/Human Resources
    Many C-Suite executives might actually prioritize this item over those previously listed. And for good reason: Medtech professionals should never underestimate or undervalue the importance of the human factor. It should be noted that businesses with the best employee engagement initiatives often have the best continuous growth in terms of organizational value (revenue, profits, etc.). During COVID-19, most C-Suite executives presumably have prioritized the health and safety of their staff. When the pandemic hit, businesses became more than indifferent conglomerations of workers and managers—they became families, with brothers and sisters universally impacted by the virus. No leader wants to lose anyone on his or her team. With COVID-19, the definition of “losing someone on the team” became expanded to being more real than anyone could have ever imagined. Perhaps this “bond of humanity” created by the pandemic will extend the goodwill and familial relationships C-Suite executives have forged with their teams. Human resource departments should be proactive about transitioning employee engagement from “COVID-19 normal” to the post-pandemic world, which hopefully will arrive sooner rather than later.

    Regardless of when the post-pandemic world arrives, it’s important for companies to consider their planned inorganic (M&A activity) this year. There has definitely been an increase in M&A deal activity during the pandemic and it seems to have become an integral part of companies’ overall growth strategies. Historically, inorganic growth during times of market disruption can be extraordinarily rewarding for future returns. With that said, its important that M&A strategies be well-considered and in-line with companies’ overall future growth strategies. History also has shown that “M&A for the sake of M&A” is rarely a good idea. Medtech organizations that decide to pursue deals in 2021 should expect valuations to be on par with 2019, though companies in financial distress will likely garner significantly less value. Since most medtech companies are in reasonably good financial shape, they must create a winning tactical execution plan for any M&A action to ensure they are truly creating long-term value. Once completing the acquisition, the management disciplines previously outlined in this column will help companies integrate their new addition’s culture and corporate structure.

    Whether companies continue their growth in 2021 organically or inorganically, there will be challenges to overcome—financially, statutorily, and administratively. But the rewards will surely be well worth the effort. 


    Florence Joffroy-Black, CM&AA, is a longtime marketing and M&A expert with significant experience in the medical technology industry, including working for multi-national corporations based in the United States, Germany, and Israel. She currently is CEO at MedWorld Advisors and can be reached at florencejblack@medworldadvisors.com.

    Dave Sheppard, CM&AA, is a former medical technology Fortune 500 executive and is now focused on M&A as a managing director at MedWorld Advisors. He can be reached at davesheppard@medworldadvisors.com.
      Loading, Please Wait..

      Trending
      • Study: Catheter Ablation Significantly Lowers Dementia Risk In AFib Patients
      • Abbott's Proclaim XR SCS OK'ed For Diabetic Neuropathy
      • BMP Medical Expands Sterling, Massachusetts Facility
      • Tandem Diabetes Completes Deal For AMF Medical
      • The Future Of Biomedical Engineering Advancements
      Breaking News
      • BMP Medical Expands Sterling, Massachusetts Facility
      • Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
      • Environmental Sustainability Becoming Increasingly Important to Medtech Industry
      • Duane DiFranco Joins Harvard MedTech’s Medical Advisory Board
      • Lionel Bonte Named President of Mativ’s Healthcare and Wellness Business Unit
      View Breaking News >
      CURRENT ISSUE

      November 2022

      • MPO's 2022 Year in Review
      • Fine Print: A Discourse on Additive Manufacturing
      • Grab and Go: Examining the Thrombectomy Device Market
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients
      Vitamin D Supplementation Reduces Risk of Dynapenia
      Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
      Coatings World

      Latest Breaking News From Coatings World

      Epoxytec Announces New Website Launch
      Paints and Coatings Market Worth $212B by 2026: MarketsandMarkets
      Axalta Releases Fourth Quarter and Full Year 2022 Results
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      BMP Medical Expands Sterling, Massachusetts Facility
      Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
      Environmental Sustainability Becoming Increasingly Important to Medtech Industry
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Pasithea Signs CMC Development and Manufacturing Agreement
      Experic Expands Analytical Capabilities and Facilities
      List Labs Expands Manufacturing Capacity
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Haircare Brand Uncle Funky’s Daughter Announces Retail Expansion
      TRESemmé Introduces New Pro Infusion Collection
      Walgreens Boots Alliance Shares 2022 ESG Report
      Happi

      Latest Breaking News From Happi

      KimChi Beauty Launches Spinning Hearts Love 02 Ahead of Valentine’s Day
      Dark & Lovely Names Actress Meagan Good Brand Ambassador
      Natural Household Care Company Tru Earth Adds Dishwasher Detergent Tablets
      Ink World

      Latest Breaking News From Ink World

      Xerox Releases 4Q, Full-Year 2022 Results
      Electronics For Imaging Names Frank Pennisi as CEO
      Fiery to Separate from EFI, Remain Wholly-Owned by Siris
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      EFI appoints Frank Pennisi CEO, Fiery now an independent business
      Bobst boosts senior sales team with Keith Nagle
      Penmar Industries adds Screen Truepress Jet L350UV SAI digital press
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Essity’s Sales Grow
      Thinx to Pay up to $5 million to Settle Class Action Suit
      Typar Highlighting New Building Innovations
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Orthofix Launches the Mariner Deformity System
      Tyber Medical Hires 2 New Execs
      Miach Ortho Raises $40M in Series B Funding
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Smart Devices with Privacy Focus Have More Consumer Appeal
      Siman Group Partners with SML to Unlock Full Retail Potential with RFID
      Brewer Science Presents Optics Integration Solutions at SPIE Photonics West

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login